Triventures ARC fund has first closing, makes initial investment

Israeli-U.S. venture capital fund Triventures launched on Tuesday a $40 million fund that will invest in early stage digital health and smart medical devices.

JERUSALEM, Sept 10 (Reuters) - Israeli-U.S. venture capital fund Triventures launched on Tuesday a $40 million fund that will invest in early stage digital health and smart medical devices.

Triventures, which is a partner with Tel Aviv's Sheba Medical Center, said it already made its first closing for the fund. A company official said the closing was for more than half of the total.

The company also said ARC made its first investment in Lynx.MD, an Israeli startup whose cloud-platform enables hospitals and medical firms to securely access and share any type of data in the healthcare environment and develop artificial intelligence-based digital health applications that improve the quality of care and reduce costs.

(Reporting by Steven Scheer)

((steven.scheer@thomsonreuters.com; +972 2 632 2210; Reuters Messaging: steven.scheer.thomsonreuters.com@reuters.net; Twitter: @StevenMScheer))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More